Unknown

Dataset Information

0

Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 Interaction.

ABSTRACT: Continued optimization of the N-substituent in the piperidinone series provided potent piperidinone-pyridine inhibitors 6, 7, 14, and 15 with improved pharmacokinetic properties in rats. Reducing structure complexity of the N-alkyl substituent led to the discovery of 23, a potent and simplified inhibitor of MDM2. Compound 23 exhibits excellent pharmacokinetic properties and substantial in vivo antitumor activity in the SJSA-1 osteosarcoma xenograft mouse model.

SUBMITTER: Yu M 

PROVIDER: S-EPMC4137378 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Continued optimization of the N-substituent in the piperidinone series provided potent piperidinone-pyridine inhibitors 6, 7, 14, and 15 with improved pharmacokinetic properties in rats. Reducing structure complexity of the N-alkyl substituent led to the discovery of 23, a potent and simplified inhibitor of MDM2. Compound 23 exhibits excellent pharmacokinetic properties and substantial in vivo antitumor activity in the SJSA-1 osteosarcoma xenograft mouse model. ...[more]

Similar Datasets

Unknown Potent and orally active small-molecule inhibitors of the MDM2-p53 interaction.
| S-EPMC2795799 | biostudies-literature
Unknown Artificial Macrocycles as Potent p53-MDM2 Inhibitors.
| S-EPMC5641952 | biostudies-literature
Unknown Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development.
| S-EPMC4027646 | biostudies-literature
Unknown P53 mdm2 inhibitors.
| S-EPMC3719986 | biostudies-literature
Unknown 8-Triazolylpurines: Towards Fluorescent Inhibitors of the MDM2/p53 Interaction.
| S-EPMC4420247 | biostudies-literature
Unknown Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screening.
| S-EPMC6223338 | biostudies-literature
Unknown Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment.
| S-EPMC4329994 | biostudies-literature
Unknown Transient protein states in designing inhibitors of the MDM2-p53 interaction.
| S-EPMC4104591 | biostudies-literature
Unknown Recent Small-Molecule Inhibitors of the p53-MDM2 Protein-Protein Interaction.
| S-EPMC7179467 | biostudies-literature
Unknown Conjugation of spermine enhances cellular uptake of the stapled peptide-based inhibitors of p53-Mdm2 interaction.
| S-EPMC3569039 | biostudies-literature